Related Experiment Video
Updated: Nov 6, 2025
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
748
Adaptive Radiation Therapy for Intact Thymoma: An Illustrative Report
Neil Chevli1, Ross E Bland2, Andrew M Farach3
1Department of Radiation Oncology, University of Texas Medical Branch at Galveston, Galveston, TX, U.S.A.
Anticancer Research
|May 6, 2021
Summary
Adaptive radiation therapy (ART) combined with induction chemoradiation is a safe and effective treatment for locally advanced thymoma. This approach reduced toxicity and achieved long-term disease control in a patient with unresectable thymoma.
Area of Science:
- Oncology
- Radiation Oncology
- Thoracic Surgery
Background:
- Induction therapy is standard for potentially resectable thymoma.
- Large disease volume in thymoma can lead to toxicity with standard chemoradiation.
- Adaptive radiation therapy (ART) may reduce normal tissue dose during induction chemoradiation for thymoma.
Observation:
- A 38-year-old male with unresectable thymoma received induction chemoradiation (cisplatin, etoposide, 45 Gy in 25 fractions).
- The radiotherapy field was adapted using ART for the final 10 fractions.
- Post-treatment thymectomy revealed Masaoka stage III disease with negative margins.
Findings:
- The patient experienced no treatment-related toxicity.
- The patient has remained disease-free for 8 years post-diagnosis.
- Induction chemoradiotherapy incorporating ART was feasible and safe.
Implications:
- ART may be a valuable tool to mitigate toxicity in locally advanced thymoma.
- This case suggests ART can be safely integrated into induction chemoradiation regimens.
- Further studies are warranted to confirm the efficacy and safety of ART in thymoma treatment.
